Committed to the future

Our technology-driven drug discovery delivers breakthroughs

Image of hero swoosh

We work in an unbroken chain — from research and discovery, through development and commercialization — to surmount the challenges of innovating in new frontiers.

Breakthrough history

Our commitment to delivering breakthroughs has produced an exciting portfolio of medicines that have the potential to change treatment paradigms and understanding of diseases.

Over the years, our portfolio has drawn from expertise in antibody engineering, fermentation technology, and manufacturing to advance new medicines to market. See more about our history here.

We continue to build on Kyowa Kirin’s rich history of innovation through new clinical programs , strategic partnerships, and by engaging with the medical and patient communities we serve.

Technology-driven drug discovery

We find inspiration for new drug discoveries in all stages of research, development, and commercialization. Our research team is working to engineer the next generation of antibodies and cell and gene therapies, with the potential to deliver life-changing value to patients in our therapeutic areas of focus: bone and mineral, intractable hematologic diseases/hemaoto oncology, and rare diseases. In La Jolla, our lab has deep expertise and a proud legacy of discovering and engineering therapeutic antibodies. We also believe in the value of strategic collaborations to advance new discoveries.

Hematopoietic Stem Cell Gene Therapies

Large image of magnified cells

Advanced Antibody Technology

Microscope image of a large collection of cells

We leverage innovative modalities for drug discovery and novel therapy realization. We aim to advance promising new therapies to market – through our internal capabilities and through strategic partnerships.

Recruitment
Fraud Alert

Contact Us

*Required

Contact Form

  • For questions related to our products, please use the links provided under Our Medicines.

By clicking the Send button, you authorize Kyowa Kirin, Inc., its affiliates, subsidiaries, and third-party agents to contact you by mail and/or email to provide information on products, programs, services, and disease-state information and/or utilize your information for market research or analytics. Kyowa Kirin, Inc., its affiliates, subsidiaries, and third-party agents will not utilize or distribute your personal information outside the above terms of consent.

Are you visiting this site from Canada? If so, consider visiting our Canadian site. It's designed to bring you up-to-date content.

 

Click "Leave Page" to visit the Kyowa Kirin Canada site.

Or click “OK” to stay on the Kyowa Kirin US site.

Option to close the window